igf-1 lr3 safety risks side effects Dosage: What to Know About Dosing, Safety, and Clinical Use Recombinant Human LR3 IGF-I/IGF-1 GMP
Description
[iii] Holt, R
Author contributions Both authors have made a substantial, direct and intellectual contribution to the work, and approved it for publication
Tested & Trusted: Your health deserves the best
They constructed a network linking major bioactive groups (e.g., saponins, flavonoids) with disturbed metabolic pathways (e.g., gut microbiota metabolism, amino acid metabolism, energy homeostasis), revealing how BYD modulates key pathological processes
